Switch to:
GuruFocus articles
Headlines from internet
Oct-23-17$64.42 (+0.00%)
01:00AMTuesday Was Blacker Than Monday; Tax Reform's Role -- Jim Cramer's Top Thoughts theStreet
06:26PMFutures and Dollar Rise as Trump Narrows Down Pool for Next Fed Chair theStreet
10:00AMThird-Quarter U.S. Economic Growth to Reveal Hurricane Damage in Week Ahead theStreet
Oct-20-17$64.42 (-0.39%)
06:49PMGet Ready for an Earnings Onslaught: Cramer's 'Mad Money' Recap theStreet
04:51PMRoche (RHHBY) Reports Sales Numbers for First 9 Months Zacks
04:28PMCancer Treatment Update: Second Gene Therapy Receives Approval Zacks
01:44PMMarket Skeptical Roche Ahead Major Trial Read Outs Seekingalpha
09:55AMGlaxo (GSK) Q3 Earnings: Will it Deliver a Beat Yet Again? Zacks
09:00AM3 Things October 20 2017 Gileads Big Day Celgenes Bad News Crohns Bristol Myers Stretches Seekingalpha
07:47AMPharma Stock Roundup: Beat & Raise Quarter from J&J, Allergan Hit by Restasis Ruling Zacks
Oct-19-17$64.67 (+1.52%)
07:40AMMarket Waiting Tax Reform Cramers Mad Money 10 18 17 Seekingalpha
Oct-18-17$63.7 (-0.75%)
03:21PMWhat to Expect from Big Pharmas After J&J's Solid Q3 Results? Zacks
02:28PMMerck: Is Keytruda a $16B Drug? Barron's
09:55AMMerck Stock Edges Higher as Citi Forecasts Strong Sales theStreet
09:00AM3 Things Biotech Learn Today October 18 2017 Seekingalpha
08:58AMExploring Astrazenecas Two Prong Assault Lung Cancer Seekingalpha
08:33AMBiogen (BIIB) Q3 Earnings: Will it Deliver a Beat Again? Zacks
06:42AMEli Lilly (LLY) to Report Q3 Earnings: What's in Store? Zacks
Oct-17-17$64.18 (+0.83%)
04:13PMUnitedHealth and a Bipartisan Healthcare Deal Sends Dow, S&P 500 to Records theStreet
12:01PMJ&J Wins Reversal of First St. Louis Talc-Cancer Verdict Bloomberg
11:07AMUnitedHealth and Johnson & Johnson Lead Bruised Healthcare Sector to Gains theStreet
10:13AMJ&J: Strong Earnings Is the Best Medicine Barron's
10:00AM3 Dividend Healthcare Stocks Fool
09:00AM3 Things Biotech Learn Today October 17 2017 Seekingalpha
08:49AMBristol-Myers Gets Priority Review for Opdivo Label Expansion Zacks
08:15AMFDA Grants Priority Review for Exelixis' RCC Drug Cabomteyx Zacks
07:32AM3 Drug Stocks Hitting 52-Week Highs: Are They Buys? Fool
04:36AMBiotech Analysis Central Daily Pharma News October 17 2017 Seekingalpha
Oct-16-17$63.65 (-2.51%)
05:10PMMercks Risk Reward Compelling Seekingalpha
04:12PMRecords for Wall Street as Apple Gains Offset Healthcare Slide theStreet
10:44AMWhat Goes Up….Is Bristol-Myers a $48 Stock? Barron's
09:23AMMorning Movers: Nordstrom Tumbles, Adobe Drops, Bristol-Myers Slips Barron's
Oct-13-17$65.29 (-0.09%)
03:14PM5 Large-Cap Drug Stocks Well Poised to Beat on Q3 Earnings Zacks
10:23AMAveo Pharmaceuticals Death Rattle Seekingalpha
09:23AMBristol-Myers (BMY), TARGET Extend Partnership for NASH Study Zacks
07:06AMPharma Stock Roundup: Pfizer Mulls Options for Consumer Healthcare, LLY's Pipeline Setback Zacks
06:09AMMccormicks Acquisition Good Cramers Lightning Round 10 12 17 Seekingalpha
06:02AMWhy High-Flying Aurinia Pharmaceuticals Stock Could Still Be Dirt Cheap Fool
Oct-12-17$65.35 (+0.37%)
08:17PMMazor Robotics, Iridium, ZAGG: 'Mad Money' Lightning Round theStreet
05:45PMNon-Alcoholic Steatohepatitis 2017 Progress Update Zacks
01:07PMLower Volatility Stock Portfolio Retirees Others Seekingalpha
12:43PMJohnson & Johnson: Another Day, Another Bullish Analyst Barron's
12:33PMWhy some think it's 'prime time' for Amazon to enter pharmacy market theStreet
10:51AMNIH partners 11 drugmakers to accelerate cancer therapy research cnbc
10:09AMInfinity Pharmaceuticals Oral Presentation Implies Near Term Upside Seekingalpha
09:18AMSeattle Genetics Inks Clinical Collaborations for Cancer Drug Zacks
06:00AM5 Game-Changing Cancer Drug Innovations Being Developed Right Now Fool
Oct-11-17$65.11 (-0.03%)
01:40PMPfizer: Who Will Pay $14B for Advil? Barron's
Oct-09-17$64.15 (-1.02%)
04:05PMAgenus Loads Impressive New Pipeline Seekingalpha
11:34AMThe 1 Event That Sent NewLink Genetics Corporation Soaring 25% in September Fool
09:55AM86 Stock Portfolio Review Q3 Dividends 16_8 Percent 2016 Seekingalpha
09:00AMPfizer Growth Trajectory Locked Ready Launch Seekingalpha
10:34AMBetter Buy: Celgene Corporation vs. Bristol-Myers Squibb Fool
08:00AM3 Things Biotech Learn Today October 7 2017 Seekingalpha
Oct-04-17$64.74 (+0.7%)
03:21PMBrunch Craft Beer Investing Busy Quarter Seekingalpha
06:00AMBristol Myers Squibb Now Time Seekingalpha
Oct-03-17$64.29 (-0.42%)
03:32PMJohnson And Johnson Best Breed Healthcare Seekingalpha
10:42AM80 Plusportfolio Update Q3 Trading Activity Want Buy Prices Seekingalpha
07:30AMOno Pharmaceutical Needs Reinvest Windfall Seekingalpha
Oct-02-17$64.56 (+1.29%)
05:19AMStarting Point Big Pharma Novartis Sanofi Clear Hurdles Seekingalpha
Sep-29-17$63.74 (+1.16%)
12:27PMIntercept Runs Trouble Nash Developers Like Galectin Gain Value Seekingalpha
Sep-28-17$63.01 (+0.1%)
02:55PMAbbvie Transitions Growth Stock Income Play Seekingalpha
11:33AMCelldex Therapeutics Buy Part 2 Seekingalpha
11:23AMGilead Spruces Large Target Market Seekingalpha
09:33AMDividend Growth Stocks Going Ex Div October 2ndminus 6th Seekingalpha
06:06AMDaily Pharma Scoop Celgenes Celmod Potential Allergans Senate Troubles Abbott Approval Surge Seekingalpha
Sep-26-17$62.93 (-0.41%)
08:00AM3 Things Biotech Learn Today September 26 2017 Seekingalpha
06:25AMDaily Pharma Scoop Alnylams Big Win Aradigm Nda Rating Exel Azn Japan Expansions Seekingalpha
06:18AMNektar Therapeutics Building Exciting Pipeline Seekingalpha
Sep-25-17$63.19 (-0.27%)
02:50PMBristol Myers Squibb Achieves Earlier Expected Win Seekingalpha
11:54AMDaily Pharma Scoop Gilead Mid 80s Keytrudas New Label Ascendiss Positive Trial Seekingalpha
08:00AM3 Things Biotech Learn Today September 24 2017 Seekingalpha
Sep-21-17$63.33 (-0.25%)
11:53AMMirati Brings Hope Stellar Performance Seekingalpha
11:03AMReasons Celldex Therapeutics Buy Part 1 Seekingalpha
08:00AM3 Things Biotech Learn Today September 21 2017 Seekingalpha
Sep-18-17$62.7 (+0.35%)
12:40PMIm Capital Strength 20 Stock Universe Russell 1000 Update September 2017 Seekingalpha
08:00AM3 Things Biotech Learn Today September 17 2017 Seekingalpha
08:00AM3 Things Biotech Learn Today September 16 2017 Seekingalpha
Sep-13-17$62.48 (-0.86%)
08:00AM3 Things Biotech Learn Today September 13 2017 Seekingalpha
05:34AMShopping Trip 80 Plus Stock Portfolio Historic Dividend Yield Prices Seekingalpha
Sep-12-17$63.02 (+0.48%)
05:16PMChips Fall Advaxis Going Q4 2017 Seekingalpha
08:00AM3 Things Biotech Learn Today September 12 2017 Seekingalpha
Sep-11-17$62.72 (+0.16%)
04:57PMWeekly Pharma Scoop Valeants Crl Resolution Eagle Undervalued Array Positive Results Seekingalpha
04:30PMQuantitative Garp Value John Bay Cfa Launched Marketplace Seekingalpha
03:57PM31 Stocks September 2017 Seekingalpha
03:19PMOutlook Regenerons Potential Break Immune Checkpoint Inhibition Seekingalpha
11:54AMCalithera Candidates May Greatly Assist Cancer Therapeutics Seekingalpha
08:00AM3 Things Biotech Learn Today September 11 2017 Seekingalpha
08:00AM3 Things Biotech Learn Today September 9 2017 Seekingalpha
Sep-08-17$62.62 (-0.35%)
03:30PMBristol Myers Squibb Gets Huge Boost Oncology Program Trial Stoppage Seekingalpha
Sep-01-17$59.9 (-0.96%)
09:24AMAnd Then There Was One: NewLink Genetics Refocuses Efforts On Indoximod, Its Remaining, Und... Seekingalpha
08:00AM3 Things In Biotech You Should Learn Today: September 1, 2017 Seekingalpha
Aug-31-17$60.48 (+1.85%)
01:36PMWhat About A Bristol-Myers Squibb Takeover By Pfizer? Seekingalpha
Aug-29-17$58.86 (+0.48%)
09:41AMTop Momentum Picks In Blue-Chip Health Care Seekingalpha
Aug-28-17$58.58 (+0.36%)
04:58PMBristol-Myers Squibb's Dividend Growth Story Marred By Limited Drug Pipeline Seekingalpha
07:49AMRetirement Planning With 20 + 2 Dividend Stocks Seekingalpha
04:45AMMy 84 Stock Portfolio - Oh, What To Buy? Evaluation Process Seekingalpha
Aug-24-17$58.17 (+0.52%)
08:26AMBiogen Maturing In Growth Seekingalpha
12:14AMDiagnosing Merck (Part 2 Of 2) Seekingalpha
Aug-22-17$57.67 (+1.82%)
05:13PMLigand: Situated For Growth Seekingalpha
04:39PMDiagnosing Merck (Part 1 Of 2) Seekingalpha
Aug-21-17$56.64 (+0.39%)
11:28AMThe IM-Capital Strength 20-Stock Universe Of The Russell 1000: Aug-2017 Update Seekingalpha
Aug-17-17$56.77 (-1.27%)
11:00AMExelixis: Time To Reach The Top Seekingalpha
Aug-16-17$57.5 (-0.64%)
06:43PM3 Things In Biotech You Should Learn Today: August 17, 2017 Seekingalpha
01:14PMBristol-Myers Squibb Combination Treatment Not At The End Of The Crossroad Seekingalpha
12:03PMOpdivo's Renal Failure Boosts Exelixis - Or Does It? Seekingalpha
11:18AMBiotech Forum Daily Digest: Revisiting Bellicum Pharmaceuticals Seekingalpha
Aug-15-17$57.87 (+0.43%)
10:54AMBristol-Myers Squibb: HIV Franchise Was Never A Big Part Of The Game Plan Seekingalpha
Aug-14-17$57.62 (+1.57%)
03:14PMMy 7.5% Income Portfolio Seekingalpha
12:15PMFibrogen And Galapagos Raise Lung Disease Hopes Seekingalpha
09:00AM3 Things In Biotech You Should Learn Today: August 13, 2017 Seekingalpha
09:00AM3 Things In Biotech You Should Learn Today: August 12, 2017 Seekingalpha
Aug-09-17$57.4 (+0.86%)
03:16AMTracking Kahn Brothers Portfolio - Q2 2017 Update Seekingalpha
Aug-07-17$56.3 (+0.63%)
08:36AMBristol-Myers - Adding To The Pipeline With IFM Seekingalpha
07:27AMDaily Insider Ratings Round Up 8/3/17: PLSE, IPI, IFF, NUVA Seekingalpha
12:09AMTeva And The Other Generics Stocks: Fair Value Discussion Seekingalpha
11:36PMBristol-Myers Squibb: A Combined Value And Growth Story Seekingalpha
09:00AM3 Things In Biotech You Should Learn Today: August 5, 2017 Seekingalpha
Aug-04-17$55.95 (+0.81%)
02:42PMSnippet Roundup: Two Approvals, Two Setbacks And A Price War Seekingalpha
11:22AMBristol's Private Sting Should Have Venture Financiers Celebrating Seekingalpha
Aug-03-17$55.5 (+0.49%)
10:33AMAfter AstraZeneca's 'Disaster', What's In Store For Their Immune Checkpoint Program? Seekingalpha
Aug-02-17$55.23 (-1.57%)
03:09PMPfizer: Why The Stock May Get Interesting Again Seekingalpha
10:45AMA Year Later, It's Still 'Hurry Up And Wait' For Roche Seekingalpha
10:36AMWhy MYSTIC Failed And How Bristol-Myers Squibb And Agenus Stand To Benefit Seekingalpha
08:19AMBristol-Myers: Looking To Maintain Lead In Immunotherapy Seekingalpha
Aug-01-17$56.11 (-1.39%)
07:17PM3 Things In Biotech You Should Learn Today: August 2, 2017 Seekingalpha
04:29PM33 Stocks For August 2017 Seekingalpha
06:51AMBuy Clovis Oncology After Big Nonsensical Drop Seekingalpha
Jul-31-17$56.9 (+2.95%)
12:36PMBiotech Forum Daily Digest: Dynavax Scores Huge Ad Comm Recommendation Seekingalpha
12:29PMThe Black Hole Seekingalpha
Jul-28-17$55.27 (+1.9%)
07:03AMWall Street Breakfast: Markets Await U.S. GDP Report Seekingalpha
Jul-27-17$54.24 (-3.11%)
10:34AMAstraZeneca: Pipeline Woes Seekingalpha
10:02AMBiohaven Pivots To Take A Shot At Migraine Seekingalpha
09:00AM3 Things In Biotech You Should Learn Today: July 27, 2017 Seekingalpha
Jul-26-17$55.98 (+0.05%)
12:46PM3 Things In Biotech You Should Learn Today: July 26, 2017 Seekingalpha
Jul-25-17$55.95 (+0.63%)
04:10PMNektar Makes A Stride Forward In Resolving Autoimmune Diseases Seekingalpha
03:12PMBiotech Bonanza: The Next Leg Up Seekingalpha
10:10AMGilead Puts Up The Good Fight Once Again Seekingalpha
07:22AMLilly Hopes To Bloom Through Nektar Attraction Seekingalpha
Jul-24-17$55.6 (-0.09%)
09:36AMA Review Of The Dividend House Portfolio: Time For A House Inspection Seekingalpha
09:00AM3 Things In Biotech You Should Learn Today: July 23, 2017 Seekingalpha
Jul-19-17$55.07 (+0.6%)
12:57PMJ&J: Some Good News, But Here's Why It's Dropped A Level Or Two Seekingalpha
11:50AMStout Opportunities: Option Trades Closed Since June 18th With 1.10% To 9.43% Returns Seekingalpha
Jul-18-17$54.74 (-0.09%)
07:23PMChaos At AstraZeneca Seekingalpha
01:58PMInvestors Waiting In BioLineRx Seekingalpha
Jul-17-17$54.79 (-0.65%)
03:55PMQuintiles IMS: A Novel Way To Invest In Biopharma Seekingalpha
02:33PMUpdates To Exelixis Thesis: Management Continues To Execute Seekingalpha
02:22PMBetting On The CAR-T Race Seekingalpha
09:00AM3 Things In Biotech You Should Learn Today: July 16, 2017 Seekingalpha
Jul-13-17$54.67 (-0.67%)
02:50PMCytRx: SCLC Study Still Breathing? Seekingalpha
Jul-12-17$55.04 (-0.52%)
09:58AMUniQure Looks To Break 6-Month Highs And Is Still Significantly Undervalued Seekingalpha
09:55AM3 Things In Biotech You Should Learn Today: July 12, 2017 Seekingalpha
Jul-11-17$55.33 (-1.07%)
11:56AM3 Things In Biotech You Should Learn Today: July 11, 2017 Seekingalpha
10:55AMInvestor Movement Index For June 2017 Seekingalpha
10:40AMVanguard Brings You High Dividend Yields Seekingalpha
Jul-10-17$55.93 (+0.04%)
06:24PMBrunch, Craft Beer, And Investing: A Millennial's Portfolio Seekingalpha
11:35AM26 Stocks For July 2017 Seekingalpha
08:47AMBristol-Myers Squibb: Strong Fundamentals Suggest Shares Are Undervalued Seekingalpha
Jul-07-17$55.91 (+1.14%)
10:23AMBig Cap Biopharma Ends The Half Year On A High Note Seekingalpha
Jul-06-17$55.28 (-1.9%)
12:21PMMerck: Good Long-Term Despite Major Setback Seekingalpha
10:53AMExelixis: Great Stock, What's Next? Seekingalpha
09:30AM3 Things In Biotech You Should Learn Today: July 6, 2017 Seekingalpha
Jul-05-17$56.35 (+0.14%)
02:54PMOpdivo And Livatag Could Add To Liver Cancer Options Seekingalpha
01:15PMAstraZeneca Can Ride High On NSCLC Opportunity In 2017 Seekingalpha
12:03PMA Look At Geron's Potential Myelofibrosis Competition Seekingalpha
03:01AMPfizer In The Garden Portfolio Seekingalpha
Jul-04-17$56.27 (+0%)
02:01PMIntangible Assets Are The Leading Source Of Moats Seekingalpha
Jul-03-17$56.27 (+0.99%)
10:02AMBristol-Myers Could Return 40% in 2 to 3 Years Barron's
Jun-30-17$55.72 (-0.18%)
03:33PMWhat To Expect From Astra's Big Binary Event Of 2017 Seekingalpha
Jun-29-17$55.82 (-0.09%)
07:40AMSyndax Locks In To Tumor Escape Seekingalpha
Jun-28-17$55.87 (-0.05%)
11:20AMComments On REVEAL, Merck's CTEP Inhibitor Study Seekingalpha
Jun-27-17$55.9 (-1.79%)
03:16PMDova Pharmaceuticals: A Different Business Model Could Lead To Success Seekingalpha
Jun-26-17$56.92 (+0.49%)
12:56PMBiotech Boom!: Overview And Company-By-Company Review Seekingalpha
10:30AM3 Things In Biotech You Should Learn Today: June 26, 2017 Seekingalpha
Jun-22-17$57.33 (+2.25%)
12:37PMBiotech Forum Daily Digest: Biotech Breaks Out! Spotlight On Aclaris Therapeutics Seekingalpha
07:56AMOnly Bristol Bucks Big Pharma's Drive For External Reliance Seekingalpha
Jun-20-17$55.66 (+0.8%)
10:30AMMore Dividend Growth Coming For Merck's Owners Seekingalpha
May-16-17$54.39 (-1.29%)
10:41AMGlycoMimetics: A New Angle On Tackling Chemo Resistance Seekingalpha
09:42AMI Think Bristol-Myers Squibb Has Finally Bottomed Seekingalpha
May-15-17$55.1 (+0.13%)
07:50AMTurmoil In Immuno-Oncology Seekingalpha
04:12AMThe Obesity Epidemic: Are Roche And Bristol-Myers Sitting On A Mighty Prospect? Seekingalpha
May-12-17$55.03 (-0.2%)
06:59PMFive Prime Therapeutics At An Attractive Entry Level Seekingalpha
03:16PMMerck Cements Its Lung Cancer Lead Seekingalpha
May-11-17$55.14 (+0%)
05:16PMKeytruda Gets Hot And Propels Merck: Analysis Seekingalpha
May-10-17$55.14 (-0.33%)
01:40PMIncyte: Good Signals From Q1 2017 Earnings Seekingalpha
12:29PMTecentriq Failure Puts Accelerated Approval In A Spin Seekingalpha
08:51AMPhysicians Look For Progress In Mesothelioma Seekingalpha
May-09-17$55.32 (+0.69%)
03:01PMCelldex Therapeutics: Nobody Expects The Spanish Inquisition Seekingalpha
01:32PMChancy Keytruda Move Sets The Stage For Chemo Combos Seekingalpha
01:02PMWhen Life Throws You A Curveball Seekingalpha
12:07PM3 Things In Biotech You Should Learn Today: May 9, 2017 Seekingalpha
05:13AMTracking Kahn Brothers Portfolio - Q1 2017 Update Seekingalpha
May-08-17$54.94 (-0.38%)
04:00PMIncyte Below $120: A 'Buy' Range For This Emerging Biotech? Seekingalpha
10:31AMBiotech Forum Daily Digest: Behind Ocular's Fall; Revisiting Progenics Seekingalpha
10:29AMPfizer's Q1 Shows Reasons Not To Buy This Icon Seekingalpha
06:25AMGilead Sciences Is A Value Trap - Cramer's Lightning Round (5/5/17) Seekingalpha
May-04-17$55.19 (+0.24%)
08:45AMAnalysis Of AbbVie's Pipeline: What's Left Of Abbott's Biopharma Growth Opportunities? Seekingalpha
May-03-17$55.06 (-1.59%)
05:41PMBristol-Myers Squibb: Dividend Cut Is Inevitable Seekingalpha
02:38PMBristol-Myers: Going Stag to the Ball? Barron's
02:10PM2017 Establishes Eliquis As The Blood-Thinner To Beat Seekingalpha

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat